Weil advised CCMP Capital Advisors and its portfolio company Milacron, a global plastics industry leader, in connection with Milacron’s acquisition of Mold-Masters, a leading global hot-runner manufacturer, from private equity firm 3i Group and other shareholders. Under the terms of the transaction, Milacron will acquire 100% of Mold-Masters for an enterprise value of C$975 million.
Private Equity partner David Blittner (New York) led the Weil team that advised CCMP and Milacron. The Weil team also included Private Equity partners Harvey Eisenberg (New York) and Thomas Schmid (Munich) and associates Sarah Stasny (New York), Alexander Clavero (New York), Ellen Wheeler (New York), Annabell Grupp (Munich), and Mareike Pfeiffer (Frankfurt); Banking & Finance counsel Christopher Gleason (Dallas) and associates Junine Johnson (New York) and Eric Min (New York); Capital Markets partner Matthew Bloch (New York) and associates Rob Beard (New York) and Laura Salvatori (New York); Antitrust counsel Vadim Brusser (Washington, DC) and associate Neil Rigby (London); Tax partner Jared Rusman (Dallas), counsel Max Goodman (New York), and associate Lane Morgan (Dallas); Executive Compensation and Employee Benefits partner Paul Wessel (New York) and associate Adam Mendelowitz (New York); Technology & IP Transactions partner Jeffrey Osterman (New York) and associate Eric Leventhal (New York); Environmental partner Annemargaret Connolly (Washington, DC) and associate Tom Goslin (Washington, DC); International Arbitration partner Chip Roh (Washington, DC) and associate Lindsay Bourne (Washington, DC); and M&A partner Anthony Wang (Shanghai) and associate Qian Meng (Shanghai).
